AstraZeneca is positioning AZD6234 as an effective treatment alternative for patients who are intolerant to incretin therapies, according to Darout, who noted that preclinical data indicate that the amylin asset could promote fat-selective weight loss
Others like Wegovys single-dose setup because theres no risk of accidentally taking the wrong dose or forgetting how much is left in the pen
However, its important to note that this injectable shouldnt be used alone
Marking the fourth and fifth positive readouts for the drug, TRIUMPH-2 (NCT05929079) and TRIUMPH-3 (NCT05882045) evaluated the first-in-class glucose-dependent insulinotropic polypeptide (GIP), GLP-1, and glucagon triple hormone receptor agonist
Helpful context before the funnel FormBlends Editorial Context Reviewed May 14, 2026 Compare three next-gen weight loss drugs: Retatrutide (24% weight loss), CagriSema (17.5% loss), and Survodutide (18.9% loss)
Clinicians at Wegovy clinics near you evaluate your specific requirements to determine suitability
